Paula Takacs Foundation for Sarcoma Research is ranked among medical research organizations in Charlotte, NC, with an America's Best Score of 83 out of 100, based on its 2025 Form 990.
Paula Takacs Foundation for Sarcoma Research is a 501(c)(3) organization, classified under Medical Research (NTEE H123). Contributions are tax-deductible.
11660 James Richard Dr, Charlotte, NC 28277-4008
Among the 4 scored medical research organizations in Charlotte, Paula Takacs Foundation for Sarcoma Research holds 19 months of operating reserves (peer median 22.8 months), runs a typical yearly surplus of 25.9% (peers: surplus of 17.1%), and has grown spending 12.8% a year (peers: grown spending 16.8% a year).
In fiscal year 2025 it reported $675,513 in revenue and $561,413 in expenses, with contributions making up 98.7% of revenue.
The mission is to raise funds for local research, amplify awareness, and accelerate the fight to end sarcoma cancers - resulting in local and global development pathway for new sarcoma treatments and increase the speed of accurate diagnoses.
Largest programs · fiscal year 2025
The paul takacs foundation for sarcoma research, a 501c(3) Tax exempt organization raises both awareness and critical funding for sarcoma research. Sarcomas currently represents approximately 1% of adult and 15% of childhood cancers, and therefore lack the level of government funding that other more prevalent cancers often receive. In addition, there are 70 different types of sarcomas, all of whic… Read more
The paul takacs foundation for sarcoma research, a 501c(3) Tax exempt organization raises both awareness and critical funding for sarcoma research. Sarcomas currently represents approximately 1% of adult and 15% of childhood cancers, and therefore lack the level of government funding that other more prevalent cancers often receive. In addition, there are 70 different types of sarcomas, all of which respond differently to treatment. With these statistics, coupled with the resistance that many sarcoma types display to traditional cancer treatments, there is a pressing need for private funding to support the effort toward more effective treatments for sarcomas.
$532,174 spent · 98.1% of program spending
Day One Program offers patient resources and comfort kits to newly diagnosed sarcoma patients and families.$10,360 spent · 1.9% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 97¢ went to programs, 2¢ to management and 1¢ to fundraising.
Programs $542,534
Management $14,413
Fundraising $4,466
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
97%
Meets
Compared with Charlotte peers
Measure
This organization
Peer median
Operating reserves
19.0 mo
22.8 mo
Typical margin
+25.9%
+17.1%
Spending growth
+12.8% / yr
+16.8% / yr
Debt load
2.2%
4.0%
Peers: the 4 Charlotte medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$675,513Fiscal year 2025
Expenses$561,413Fiscal year 2025
Total assets$906,963Fiscal year 2025
Total liabilities$20,000Fiscal year 2025
Fiscal year ending December2025
Revenue$675,513
Expenses$561,413
Net income$114,100
Net assets$886,963
Notable sources of revenue
Percent of total revenue
Contributions
$666,662
98.7%
Program services
$0
0.0%
Investment income
$8,851
1.3%
Other (net)
$0
0.0%
Assets / debt
Total assets
$906,963
Total liabilities
$20,000
Net assets
$886,963
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$624,980
Expenses$568,454
Net income$56,526
Net assets$772,863
Notable sources of revenue
Percent of total revenue
Contributions
$623,792
99.8%
Program services
$0
0.0%
Investment income
$1,188
0.2%
Other (net)
$0
0.0%
Assets / debt
Total assets
$1,117,863
Total liabilities
$345,000
Net assets
$772,863
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$578,647
Expenses$440,029
Net income$138,618
Net assets$716,337
Notable sources of revenue
Percent of total revenue
Contributions
$577,774
99.8%
Program services
$0
0.0%
Investment income
$873
0.2%
Other (net)
$0
0.0%
Assets / debt
Total assets
$718,099
Total liabilities
$1,762
Net assets
$716,337
Compensation
Officers and key employees
$56,625
Share of expenses
12.9%
Fiscal year ending December2022
Revenue$617,474
Expenses$391,068
Net income$226,406
Net assets$576,630
Notable sources of revenue
Percent of total revenue
Contributions
$617,474
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$577,201
Total liabilities
$571
Net assets
$576,630
Compensation
Officers and key employees
$50,500
Share of expenses
12.9%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?